Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatoma
- 1 July 1984
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 10 (7), 1135-1141
- https://doi.org/10.1016/0360-3016(84)90188-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Variables affecting the tumor localization of131 I-antiferritin in experimental hepatomaAmerican Journal of Clinical Oncology, 1984
- Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibodyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Cellular distribution of monoclonal antibody in human tumours after i.v. administrationBritish Journal of Cancer, 1981
- Fc and complement receptors on malignant tumor cellsCancer, 1981
- Localization of human tumour xenografts after i.v. administration of radiolabelled monoclonal antibodiesBritish Journal of Cancer, 1981
- Dosimetry of 131I-labeled anti-ferritin in hepatoma: A model for radioimmunoglobulin dosimetryInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Antiferritin IgG Antibody for Isotopic Cancer TherapyOncology, 1981
- Cyclophosphamide as an adjuvant to X-rays in treatment of a radioresistant solid tumor of the rat, hepatoma H-4-II-EInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Adriamycin and X-radiation effects upon an experimental solid tumor resistant to therapyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Studies Directed Toward the use of Antibodies as Carriers of Radioactivity for TherapyPublished by Elsevier ,1957